牛磺酸上调基因1作为主调控因子协调肝细胞癌的糖酵解与转移
该研究探讨肝细胞癌(HCC)中糖酵解代谢与转移的关系。研究发现敲低牛磺酸上调基因1(TUG1)通过抑制miR-455-3p显著抑制细胞迁移、侵袭和糖酵解;miR-455-3p受p21转录抑制,直接靶向AMPKβ2的3'非翻译区;TUG1/miR-455-3p/AMPKβ2轴通过调控己糖激酶2(HK2)调节细胞生长、转移和糖酵解。TUG1与HCC患者HK2过表达及不良预后明显相关。
要点
- 敲低TUG1通过抑制miR-455-3p显著抑制HCC细胞迁移、侵袭和糖酵解。
- miR-455-3p受p21转录抑制,直接靶向AMPKβ2的3'非翻译区。
- TUG1/miR-455-3p/AMPKβ2轴通过调控HK2影响HCC细胞生长、转移和糖酵解。
核心结论
- TUG1、miR-455-3p、AMPKβ2和HK2之间的新调控关联是HCC细胞糖酵解代谢和转移的重要决定因素,并支持靶向TUG1/HK2作为HCC治疗策略的潜在用途。
研究设计与样本
- 基础研究,探究TUG1在HCC细胞糖酵解与转移中的调控机制。
主要发现
- 敲低TUG1通过抑制miR-455-3p显著抑制细胞迁移、侵袭和糖酵解。
- miR-455-3p受p21转录抑制,直接靶向AMPKβ2的3'非翻译区。
- TUG1/miR-455-3p/AMPKβ2轴通过调控HK2调节细胞生长、转移和糖酵解。
- TUG1与HCC患者HK2过表达及不良预后明显相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Cancer cells display altered glucose metabolism characterized by a preference for aerobic glycolysis. The aerobic glycolytic phenotype of hepatocellular carcinoma (HCC) is often correlated with tumor progression and poorer clinical outcomes. However, the issue of whether glycolytic metabolism influences metastasis in HCC remains unclear. In the current study, we showed that knockdown of taurine up-regulated gene 1 (TUG1) induces marked inhibition of cell migration, invasion, and glycolysis through suppression of microRNA (miR)-455-3p. MiR-455-3p, which is transcriptionally repressed by p21, directly targets the 3' untranslated region of adenosine monophosphate-activated protein kinase subunit beta 2 (AMPKβ2). The TUG1/miR-455-3p/AMPKβ2 axis regulates cell growth, metastasis, and glycolysis through regulation of hexokinase 2 (HK2). TUG1 is clearly associated with HK2 overexpression and unfavorable prognosis in HCC patients. CONCLUSION: Our data collectively highlight that novel regulatory associations among TUG1, miR-455-3p, AMPKβ2, and HK2 are an important determinant of glycolytic metabolism and metastasis in HCC cells and support the potential utility of targeting TUG1/HK2 as a therapeutic strategy for HCC. (Hepatology 2018;67:188-203).
引用
- Lin YH, Wu MH, Huang YH, et al. Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Hepatology. 2017. PMID: 28802060. doi:10.1002/hep.29462
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。